SCHEMBL7091095

SCHEMBL7091095

Cc1nc(N=Nc2cccc(C(=O)O)c2Cl)c(COP(=O)(O)O)c(C=O)c1O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 4/20 0.71
P2RX7 Q99572 3/20 0.67
YWHAG P61981 1/20 0.67
YWHAZ P63104 1/20 0.67
P2RY13 Q9BPV8 4/20 0.61
MAPT P10636 7/20 0.59
TDP1 Q9NUW8 7/20 0.59
KDM4E B2RXH2 5/20 0.59
KMT2A Q03164 5/20 0.59
HPGD P15428 4/20 0.59
MEN1 O00255 3/20 0.59
HSD17B10 Q99714 3/20 0.59
P2RX3 P56373 2/20 0.59
P2RX2 Q9UBL9 2/20 0.59
ALDH1A1 P00352 2/20 0.59
CASP1 P29466 1/20 0.59
CYP2C19 P33261 1/20 0.59
RAB9A P51151 1/20 0.59
CASP7 P55210 1/20 0.59
P2RX5 Q93086 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7095149 0.91 P2RX7 (0.69) P2RY1P2RX7YWHAGYWHAZP2RY13
SCHEMBL7093650 0.91 P2RX7 (0.71) P2RY1P2RX7YWHAGYWHAZP2RY13
SCHEMBL7092943 0.90 P2RX7 (0.68) P2RY1P2RX7YWHAGYWHAZP2RY13
SCHEMBL13962115 0.85 P2RY1 (0.71) P2RY1P2RX7YWHAGYWHAZP2RY13
SCHEMBL7093360 0.82 P2RX7 (0.75) P2RY1P2RX7YWHAGYWHAZP2RY13
SCHEMBL7090286 0.80 P2RX7 (0.64) P2RY1P2RX7YWHAGYWHAZP2RY13
SCHEMBL25271476 0.80 P2RX7 (1.00) P2RY1P2RX7YWHAGYWHAZP2RY13
SCHEMBL32686684 0.80 P2RX7 (1.00) P2RY1P2RX7YWHAGYWHAZP2RY13
SCHEMBL14702229 0.80 P2RX7 (1.00) P2RY1P2RX7YWHAGYWHAZP2RY13
SCHEMBL7093732 0.80 P2RX7 (0.78) P2RY1P2RX7YWHAGYWHAZP2RY13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6638921-B1 Pharmaceutically acceptable derivatives thereof Cx, R1 and R2 being as defined in the disclosure may be used to inhibit the activity of HIV integrase. PHARMACOR INC. (CA) 2003-10-28 US disclosed
WO-2003082881-A2 PYRIDOXAL-5-PHOSPHATE DERIVATIVES AS HIV INTEGRASE INHIBITORS PROCYON BIOPHARMA INC. (CA) 2003-10-09 WO disclosed